Latest News

A new review aims to help clinicians better recognize subtle signs of pneumonitis before they escalate.

For Erica Herzog, MD, PhD, being a mentor is a privilege that is immensely fulfilling. This summer, two of Herzog’s mentees met career benchmarks, and both credit Herzog and her guidance for getting them there.

A new study from Yale researchers identifies an epithelial-immune signaling pathway crucial to the lung’s injury-repair process. When this signaling is altered, the study shows, it may help push the lung toward fibrosis.

When Naftali Kaminski, MD, was recruited to Yale in 2013 as section chief of Pulmonary, Critical Care and Sleep Medicine (Yale-PCCSM) he planned to lead it for 10 years. Now, coming up on his thirteenth year, he is stepping down at the end of June 2026.

Each year, the American College of Chest Physicians (CHEST) honors the clinicians, researchers, and educators shaping the future of chest medicine. Among this year’s distinguished honorees are several faculty members from the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine (Yale-PCCSM), recognized for their leadership, innovation, and dedication to the field.

The Department of Internal Medicine welcomes the following new faculty, postdocs, and postgrads who joined the team in August 2025

A new Yale-led study sheds light on how asthma behaves differently in males and females, both in symptoms and at the level of gene expression.

Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure.

Yale researchers developed an AI model that illuminates critical details about—and possible treatments for—idiopathic pulmonary fibrosis. It could do so for many other diseases.